Evidence map›Paper›PMID 33989378›Full record

ReviewCardiovascular research2022

Heterogeneous subpopulations of adventitial progenitor cells regulate vascular homeostasis and pathological vascular remodelling.

Austin J Jolly, Sizhao Lu, Keith A Strand, Allison M Dubner, Marie F Mutryn, Raphael A Nemenoff, Mark W Majesky, Karen S Moulton, Mary C M Weiser-Evans

Open access · bronzeAbstract readReview
In one paragraph

Review in Cardiovascular research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Single-Cell Multimodal Profiling Reveals a Novel CD26Arteriosclerosis, thrombosis, and vascular biology · 2025
    Article
  9. Promising Adventitia in Atherosclerosis.Current vascular pharmacology · 2025
    Review
  10. Review
  11. Article
  12. Stem cell antigen-1Cellular and molecular life sciences : CMLS · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Extracellular Matrix in Aging Aorta.Frontiers in cell and developmental biology · 2022
    Review
  19. Vascular Stem/Progenitor Cells in Vessel Injury and Repair.Frontiers in cardiovascular medicine · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Austin J JollyDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.ORCID 0000-0001-6458-4648
Sizhao LuDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.ORCID 0000-0002-9892-8784
Keith A StrandDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.
Allison M DubnerDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.ORCID 0000-0001-8027-7410
Marie F MutrynDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.ORCID 0000-0003-2166-6904
Raphael A NemenoffDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.ORCID 0000-0002-2369-2535
Mark W MajeskyCenter for Developmental Biology & Regenerative Medicine, Seattle Children's Research Center, 1900 9th Avenue, Seattle, WA 98101, USA.
Karen S MoultonDepartment of Medicine, Division of Cardiology, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.
Mary C M Weiser-EvansDivision of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Anschutz Medical Campus, 12700 East 19th Avenue, Aurora, CO 80045, USA.ORCID 0000-0002-6239-2412
University of Colorado Anschutz Medical Campus · USSeattle Children's Hospital · US

Funding

Medical Scientist Training ProgramT32GM008497 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI WILSON, CARA C. · 1993 to 2022
$15.2M
Reprogramming of mature smooth muscle cells to vascular progenitor cellsR01HL121877 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI MARK W. MAJESKY, Mary CM Weiser-Evans · 2015 to 2026
$7.8M
POSTGRADUATE TRAINING IN CARDIOVASCULAR RESEARCHT32HL007822 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI BUTTRICK, PETER N., LEINWAND, LESLIE ANNE · 1996 to 2023
$6.2M
PREDOCTORAL TRAINING PROGRAM IN PHARMACOLOGYT32GM007635 · NIGMS · UNIVERSITY OF COLORADO DENVER · PI DELL'ACQUA, MARK L · 1985 to 2023
$6.1M
PTEN promoter hypermethylation underlies vascular disease progressionR01HL151331 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI WEISER-EVANS, MARY CM · 2021 to 2024
$2.3M
PTEN-dependent regulation of SRF transcriptional activity and SMC phenotype controlR01HL123616 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI WEISER-EVANS, MARY CM. · 2015 to 2018
$2.0M
Pharmacologic PTEN upregulation: A novel therapeutic approach to prevent pathological vascular remodeling and fibrosisF31HL147393 · NHLBI · UNIVERSITY OF COLORADO DENVER · PI STRAND, KEITH · 2019 to 2020
$53k
NHLBI NIH HHS F31 HL147393NHLBI NIH HHS R01 HL121877NHLBI NIH HHS R01 HL123616NHLBI NIH HHS R01 HL151331NHLBI NIH HHS T32 HL007822NIGMS NIH HHS T32 GM007635NIGMS NIH HHS T32 GM008497
6 · The paper itself

Abstract

Cardiovascular diseases are characterized by chronic vascular dysfunction and provoke pathological remodelling events, such as neointima formation, atherosclerotic lesion development, and adventitial fibrosis. While lineage-tracing studies have shown that phenotypically modulated smooth muscle cells (SMCs) are the major cellular component of neointimal lesions, the cellular origins and microenvironmental signalling mechanisms that underlie remodelling along the adventitial vascular layer are not fully understood. However, a growing body of evidence supports a unique population of adventitial lineage-restricted progenitor cells expressing the stem cell marker, stem cell antigen-1 (Sca1; AdvSca1 cells) as important effectors of adventitial remodelling and suggests that they are at least partially responsible for subsequent pathological changes that occur in the media and intima. AdvSca1 cells are being studied in murine models of atherosclerosis, perivascular fibrosis, and neointima formation in response to acute vascular injury. Depending on the experimental conditions, AdvSca1 cells exhibit the capacity to differentiate into SMCs, endothelial cells, chondrocytes, adipocytes, and pro-remodelling cells, such as myofibroblasts and macrophages. These data indicate that AdvSca1 cells may be a targetable cell population to influence the outcomes of pathologic vascular remodelling. Important questions remain regarding the origins of AdvSca1 cells and the essential signalling mechanisms and microenvironmental factors that regulate both maintenance of their stem-like, progenitor phenotype and their differentiation into lineage-specified cell types. Adding complexity to the story, recent data indicate that the collective population of adventitial progenitor cells is likely composed of several smaller, lineage-restricted subpopulations, which are not fully defined by their transcriptomic profile and differentiation capabilities. The aim of this review is to outline the heterogeneity of Sca1+ adventitial progenitor cells, summarize their role in vascular homeostasis and remodelling, and comment on their translational relevance in humans.

Indexed as

AtherosclerosisSpinocerebellar AtaxiasAnimalsCell DifferentiationEndothelial CellsFibrosisHomeostasisMiceMyocytes, Smooth MuscleNeointimaStem CellsVascular RemodelingAdvSca1 cellsAtherosclerosisNeointima formationPathological vascular remodellingVascular fibrosis

Identifiers

PMID33989378
PMCPMC9074982
OpenAlexW3161845713

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.